Cme Group annual revenue
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Cme Group Revenue Growth & History (CME)
Cme Group reported $6.52B in revenue for fiscal 2025, an increase of 6.37% from the previous fiscal year.
View full Cme Group company overviewCme Group annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $6.52B | $390.5M | +6.37% |
| 2024 | 2024-12-31 | $6.13B | $551.2M | +9.88% |
| 2023 | 2023-12-31 | $5.58B | $559.5M | +11.15% |
| 2022 | 2022-12-31 | $5.02B | $329.7M | +7.03% |
| 2021 | 2021-12-31 | $4.69B | −$193.9M | −3.97% |
| 2020 | 2020-12-31 | $4.88B | $15.6M | +0.32% |
| 2019 | 2019-12-31 | $4.87B | $558.6M | +12.96% |
| 2018 | 2018-12-31 | $4.31B | $664.7M | +18.24% |
| 2017 | 2017-12-31 | $3.64B | $49.5M | +1.38% |
| 2016 | 2016-12-31 | $3.60B | $268.4M | +8.07% |
| 2015 | 2015-12-31 | $3.33B | $214.3M | +6.89% |
| 2014 | 2014-12-31 | $3.11B | $176.2M | +6.00% |
| 2013 | 2013-12-31 | $2.94B | $21.7M | +0.74% |
| 2012 | 2012-12-31 | $2.91B | −$366.0M | −11.16% |
| 2011 | 2011-12-31 | $3.28B | $276.9M | +9.22% |
| 2010 | 2010-12-31 | $3.00B | $390.9M | +14.96% |
| 2009 | 2009-12-31 | $2.61B | $51.8M | +2.02% |
| 2008 | 2008-12-31 | $2.56B | $804.9M | +45.83% |
| 2007 | 2007-12-31 | $1.76B | — | — |
Cme Group quarterly revenue
Q2.08
Q3.08
Q1.09
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.71B | $14.2M | +0.84% |
| Q1 2026 | 2026-03-31 | $1.88B | $237.8M | +14.48% |
| Q4 2025 | 2025-12-31 | $1.65B | $123.4M | +8.09% |
| Q3 2025 | 2025-09-30 | $1.54B | −$46.8M | −2.95% |
| Q2 2025 | 2025-06-30 | $1.69B | $159.5M | +10.41% |
| Q1 2025 | 2025-03-31 | $1.64B | $154.4M | +10.38% |
| Q4 2024 | 2024-12-31 | $1.53B | $86.0M | +5.98% |
| Q3 2024 | 2024-09-30 | $1.58B | $246.6M | +18.43% |
| Q2 2024 | 2024-06-30 | $1.53B | $172.3M | +12.67% |
| Q1 2024 | 2024-03-31 | $1.49B | $46.3M | +3.21% |
| Q4 2023 | 2023-12-31 | $1.44B | $231.5M | +19.17% |
| Q3 2023 | 2023-09-30 | $1.34B | $110.0M | +8.96% |
| Q2 2023 | 2023-06-30 | $1.36B | $123.0M | +9.94% |
| Q1 2023 | 2023-03-31 | $1.44B | $95.0M | +7.05% |
| Q4 2022 | 2022-12-31 | $1.21B | $60.5M | +5.27% |
| Q3 2022 | 2022-09-30 | $1.23B | $117.9M | +10.62% |
| Q2 2022 | 2022-06-30 | $1.24B | $58.0M | +4.92% |
| Q1 2022 | 2022-03-31 | $1.35B | $93.3M | +7.44% |
| Q4 2021 | 2021-12-31 | $1.15B | $48.8M | +4.44% |
| Q3 2021 | 2021-09-30 | $1.11B | $29.2M | +2.70% |
| Q2 2021 | 2021-06-30 | $1.18B | −$3.1M | −0.26% |
| Q1 2021 | 2021-03-31 | $1.25B | −$268.8M | −17.66% |
| Q4 2020 | 2020-12-31 | $1.10B | −$39.9M | −3.50% |
| Q3 2020 | 2020-09-30 | $1.08B | −$196.6M | −15.39% |
| Q2 2020 | 2020-06-30 | $1.18B | −$90.4M | −7.10% |
| Q1 2020 | 2020-03-31 | $1.52B | $342.5M | +29.04% |
| Q4 2019 | 2019-12-31 | $1.14B | −$98.2M | −7.94% |
| Q3 2019 | 2019-09-30 | $1.28B | $373.1M | +41.26% |
| Q2 2019 | 2019-06-30 | $1.27B | $213.1M | +20.11% |
| Q1 2019 | 2019-03-31 | $1.18B | $70.6M | +6.37% |
| Q4 2018 | 2018-12-31 | $1.24B | $336.6M | +37.40% |
| Q3 2018 | 2018-09-30 | $904.2M | $13.4M | +1.50% |
| Q2 2018 | 2018-06-30 | $1.06B | $135.0M | +14.60% |
| Q1 2018 | 2018-03-31 | $1.11B | $179.7M | +19.34% |
| Q4 2017 | 2017-12-31 | $900.0M | −$12.9M | −1.41% |
| Q3 2017 | 2017-09-30 | $890.8M | $49.1M | +5.83% |
| Q2 2017 | 2017-06-30 | $924.6M | $18.2M | +2.01% |
| Q1 2017 | 2017-03-31 | $929.3M | −$4.9M | −0.52% |
| Q4 2016 | 2016-12-31 | $912.9M | $99.1M | +12.18% |
| Q3 2016 | 2016-09-30 | $841.7M | −$8.6M | −1.01% |
| Q2 2016 | 2016-06-30 | $906.4M | $86.4M | +10.54% |
| Q1 2016 | 2016-03-31 | $934.2M | $91.5M | +10.86% |
| Q4 2015 | 2015-12-31 | $813.8M | −$27.3M | −3.25% |
| Q3 2015 | 2015-09-30 | $850.3M | $87.9M | +11.53% |
| Q2 2015 | 2015-06-30 | $820.0M | $88.4M | +12.08% |
| Q1 2015 | 2015-03-31 | $842.7M | $65.3M | +8.40% |
| Q4 2014 | 2014-12-31 | $841.1M | $154.1M | +22.43% |
| Q3 2014 | 2014-09-30 | $762.4M | $47.8M | +6.69% |
| Q2 2014 | 2014-06-30 | $731.6M | −$84.5M | −10.35% |
| Q1 2014 | 2014-03-31 | $777.4M | $58.8M | +8.18% |
| Q4 2013 | 2013-12-31 | $687.0M | $26.1M | +3.95% |
| Q3 2013 | 2013-09-30 | $714.6M | $31.4M | +4.60% |
| Q2 2013 | 2013-06-30 | $816.1M | $20.2M | +2.54% |
| Q1 2013 | 2013-03-31 | $718.6M | −$56.0M | −7.23% |
| Q4 2012 | 2012-12-31 | $660.9M | −$75.6M | −10.26% |
| Q3 2012 | 2012-09-30 | $683.2M | −$191.0M | −21.85% |
| Q2 2012 | 2012-06-30 | $795.9M | −$42.4M | −5.06% |
| Q1 2012 | 2012-03-31 | $774.6M | −$57.0M | −6.85% |
| Q4 2011 | 2011-12-31 | $736.5M | −$26.7M | −3.50% |
| Q3 2011 | 2011-09-30 | $874.2M | $140.8M | +19.20% |
| Q2 2011 | 2011-06-30 | $838.3M | $24.4M | +3.00% |
| Q1 2011 | 2011-03-31 | $831.6M | $138.4M | +19.97% |
| Q4 2010 | 2010-12-31 | $763.2M | $95.7M | +14.34% |
| Q3 2010 | 2010-09-30 | $733.4M | $83.0M | +12.76% |
| Q2 2010 | 2010-06-30 | $813.9M | $166.1M | +25.64% |
| Q1 2010 | 2010-03-31 | $693.2M | $46.1M | +7.12% |
| Q4 2009 | 2009-12-31 | $667.5M | — | — |
| Q3 2009 | 2009-09-30 | $650.4M | −$30.5M | −4.48% |
| Q2 2009 | 2009-06-30 | $647.8M | $84.6M | +15.02% |
| Q1 2009 | 2009-03-31 | $647.1M | — | — |
| Q3 2008 | 2008-09-30 | $680.9M | — | — |
| Q2 2008 | 2008-06-30 | $563.2M | — | — |
Cme Group revenue growth trends
Over the last five reported fiscal years, revenue grew from $4.88B to $6.52B, a compound annual growth rate of 5.95%. Cme Group's latest reported quarter, Q2 2026, generated $1.71B in revenue, an increase of 0.84% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Cme Group source filings ↗Community posts
CME plans European dairy futures and options through EEX transition
CME Group ($CME) agreed with the European Energy Exchange to transition EEX’s European dairy business, including its butter and skimmed-milk-powder indices, as EEX phases out those products. CME plans to establish its own European dairy ind ...
CME sets an FX open-interest record of 4.41 million contracts
CME Group reported a new foreign-exchange derivatives milestone on 7 September 2026. Reported records FX futures and options open interest reached 4,410,167 contracts on 4 September, exceeding the previous 4,269,622 record from 11 June. Tha ...
